Last November, a Du Port Road resident filed a complaint with the Forestry Development Authority (FDA), claiming a large plot ...

A conference call will be held today, April 25, 2025, at 16:00 CEST (15:00 BST / 10:00 EDT / 07:00 PDT) to review the ...

Akeso, Inc. (9926.HK) ("Akeso" or the "Company") is excited to announce that the U.S. Food and Drug Administration (FDA) has approved its differentiated PD-1 monoclonal antibody, penpulimab-kcqx, in ...

Presentations at this year’s American Association for Cancer Research meeting could have a broad impact on the treatment landscape for head and neck and lung cancer, and implications for specific drug ...

Saini inaugurated 923 development projects valued at ₹233 crore and laid the foundation stones for 413 additional projects, ...

Akeso, Inc. (9926.HK) ('Akeso' or the 'Company') is excited to announce that the U.S. Food and Drug Administration (FDA) has approved its differentiated PD-1 monoclonal antibody, penpulimab-kcqx, in ...

The FDA is phasing out animal testing and moving to more human-relevant methods. This was announced as one of Marty Makary’s ...

Gilead Sciences on Thursday reported a first-quarter profit, but revenue was flat, as higher sales of drugs for HIV and liver ...

Not all Pillsbury Funfetti frostings contain synthetic food colorings, but many do, especially the ones with bright colors.

Crispr Therapeutics is an emerging gene editing company focused on the development of Crispr/Cas9-based therapeutics. The company's proprietary platform specializes in clustered regularly interspaced ...

As they campaigned in B.C., Global News sat down for a one-on-one interview with Conservative Leader Pierre Poilievre, Liberal Leader Mark Carney and NDP Leader Jagmeet Singh.

STAT reporters chat about pharma tariffs, the latest recovery in biotech stocks, and disappointing data from a Bristol Myers ...